GlassScriptPhysician profile
Kathren D Mccarty
NPI 1154505089
$3,243.36
in general payments reported to CMS, 2019-2025
15 companies · $470 in 2025
The $470 reported for 2025 was more than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $875 · 2020: $156 · 2021: $211 · 2022: $354 · 2023: $1,040 · 2024: $137 · 2025: $470.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,637 · Travel and Lodging: $10.32.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,636.90 |
| Travel and Lodging | $10.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,667.18 | 2019-2025 | Augment Injectable, Allograft, Axsos |
| Medinc of Texas | $707.00 | 2019 | |
| Nvision Biomedical Technologies, INC. | $196.07 | 2023 | Foot and Ankle |
| Treace Medical Concepts, INC. | $164.63 | 2022-2025 | |
| Mission Medical Distribution, LLC | $143.73 | 2023 | |
| Janssen Pharmaceuticals, INC | $119.04 | 2021 | |
| Organogenesis INC. | $102.02 | 2023 | Puraply |
| Wright Medical Technology, INC. | $49.27 | 2019-2020 | |
| Bioventus LLC | $23.82 | 2021 | |
| Ibsa Pharma INC. | $18.45 | 2023 | Tirosint, Licart |
| Kerecis Limited | $14.25 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Ossdsign USA Incorporated | $13.87 | 2025 | Ossdsign Catalyst |
| Merck Sharp & Dohme LLC | $12.03 | 2019 | |
| Medtronic, INC. | $12.00 | 2022 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$525,000.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kathren Mccarty listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.